Results 21 to 30 of about 20,467 (239)

Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT

Health Technology Assessment, 2022
Background: The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of  400 µm.
Noemi Lois, Christina Campbell, Norman Waugh, Augusto Azuara-Blanco, Mandy Maredza, Hema Mistry, Danny McAuley, Nachiketa Acharya, Tariq M Aslam, Clare Bailey, Victor Chong, Louise Downey, Haralabos Eleftheriadis, Samia Fatum, Sheena George, Faruque Ghanchi, Markus Groppe, Robin Hamilton, Geeta Menon, Ahmed Saad, Sobha Sivaprasad, Marianne Shiew, David H Steel, James Stephen Talks, Paul Doherty, Clíona McDowell, Mike Clarke   +26 more
doaj   +1 more source

Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema [PDF]

European Ophthalmic Review, 2010
Diabetic macular oedema is a major cause of severe visual loss whose pathogenesis appears to be complex and multifactorial. For many years laser photocoagulation has been the standard of care for the treatment of this condition. Emerging pharmacologic approaches are being evaluated through randomised controlled trials.
SARAO, Valentina, VERITTI, Daniele, LANZETTA, Paolo   +2 more
openaire   +3 more sources

Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]

, 2010
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Al Saeidi, Rashid, Haritoglou, Christos, Kook, Daniel, Kreutzer, Thomas C., Neubauer, Aljoscha Steffen, Ulbig, Michael W., Wolf, Armin   +6 more
core   +1 more source

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study

BMC Ophthalmology, 2011
Background Diabetic macular oedema is the leading causes of blindness. Laser photocoagulation reduces the risk of visual loss. However recurrences are common and despite laser treatment, patients with diabetic macular oedema experienced progressive loss ...
Norlaili Mustapha, Bakiah Shaharuddin, Zunaina Embong   +2 more
doaj   +1 more source

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment : evidence from the RESTORE trial [PDF]

, 2012
Background/aims To evaluate the cost-effectiveness of ranibizumab as either monotherapy or combined with laser therapy, compared with laser monotherapy, in the treatment of diabetic macular oedema (DME) causing visual impairment from a UK healthcare ...
Mitchell, Paul, Annemans, Lieven, Gallagher, Meghan, Hasan, Rafiq, Thomas, Simu, Gairy, Kerry, Knudsen, Martin, Onwordi, Henrietta   +7 more
core   +2 more sources

The management of diabetic macular oedema

Saudi Journal of Ophthalmology, 2011
Diabetic macular oedema (DMO) is a significant cause of visual loss in the working population. Focal/grid photocoagulation remains an effective treatment for DMO and the benchmark to which clinicians compare other newer treatment modalities. There are, however, patients who do not respond adequately or who are refractory to laser photocoagulation. This
Ross, Adam H., Clare Bailey, C.
openaire   +2 more sources

Intravitreal triamcinolone for diffuse diabetic macular oedema [PDF]

Eye, 2005
To evaluate the efficacy of intravitreal triamcinolone (IVTA) for the treatment of diffuse diabetic macular oedema (DME) refractory to conventional argon macular laser therapy.A prospective, consecutive, and noncomparative case series was undertaken involving 38 eyes of 38 patients with refractory DME.
S K, Gibran, A, Cullinane, S, Jungkim, P E, Cleary   +3 more
openaire   +2 more sources

Vitrectomy for diabetic macular oedema [PDF]

Eye, 2008
To briefly review and discuss the literature on vitrectomy for diabetic macular oedema.Literature review.There is a copious literature on the subject of vitrectomy for diabetic macular oedema (DMO). The most commonly hypothesised mechanism for the potential benefit of vitrectomy is relief of vitreomacular traction; however, both transvitreal ...
openaire   +2 more sources

Ganglion cell complex changes with long-standing diabetic macular oedema among Egyptian diabetic patients: an optical coherence tomography study

Journal of the Egyptian Ophthalmological Society, 2018
Introduction Optical coherence tomography (OCT) is a valuable tool for imaging retinal thickness and structure as well as performing good evaluation for the ganglion cell complex (GCC) parameters, reflecting the status of retinal nerve fiber layer, the ...
Tamer A Refai, Amre A.H Hassan
doaj   +1 more source

Effect of Intravitreal Injection of Ranibizumab on Diabetic Macular Oedema at a Tertiary Centre in West Bengal: A Prospective Study [PDF]

Journal of Clinical and Diagnostic Research, 2023
Introduction: Diabetic Retinopathy (DR) is one among the many causes of visual loss in people all over the world. Diabetic Macular Oedema (DME) is the most common among vision threatening complications of DR, with a major impact on quality of life of the
Vysakh Balan, Atanu Biswas
doaj   +1 more source